United Kingdom Metagenomics Market Size, Share, and COVID-19 Impact Analysis, By Technology (Shotgun Sequencing, 16S Sequencing, Whole Genome Sequencing, and Others), By Application (Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food & nutrition, and Others), and United Kingdom metagenomics Market Insights, Industry Trend, Forecasts to 2035.
Industry: HealthcareUnited Kingdom Metagenomics Market Insights Forecasts to 2035
- The United Kingdom Metagenomics Market Size was estimated at USD 114.63 Million in 2024
- The Market Size is Expected to Grow at a CAGR of around 13.75% from 2025 to 2035
- The United Kingdom Metagenomics Market Size is Expected to Reach USD 473.10 Million by 2035
Get more details on this report -
According to a research report published by Spherical Insights and Consulting, the United Kingdom Metagenomics Market Size is anticipated to reach USD 473.10 Million by 2035, growing at a CAGR of 13.75% from 2025 to 2035. The market is growing due to well-developed infrastructure as well as a long history of funding scientific research, substantial financing from government funding agencies, private organizations, and pharmaceutical companies. Moreover, the development of metagenomics technology and applications is accelerated, collaboration is facilitated, and creativity is stimulated.
Market Overview
The United Kingdom metagenomics market refers to the industry focused on as the sector that creates, uses, and markets instruments and technologies to examine the genetic material (DNA/RNA) found in environmental samples, such as soil, water, air, and human microbiomes, without the need to cultivate organisms in a lab. The main drivers are ongoing technology developments, especially in sequencing technologies with the introduction of next-generation sequencing (NGS), which has become more accurate, efficient, and economical. The need for metagenomic research to comprehend the impact of microbial communities on immunity, health, and disease prevention has grown as a result of investigations into human, animal, and environmental microbiomes. Environmental and industrial applications like pathogen detection, soil health evaluation, and biodiversity monitoring are also propelling this market's expansion. Further, the government is enforcing steps such as the UK Health Security Agency (UKHSA) has launched mSCAPE—a world-first metagenomic surveillance initiative designed to bolster the UK’s health security by enabling rapid detection of infectious diseases. mSCAPE is a major leap toward a more agile, predictive public health system that exceeds the market growth.
Report Coverage
This research report categorizes the market for the United Kingdom metagenomics market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom metagenomics market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom metagenomics market.
United Kingdom Metagenomics Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Market Size in 2024: | USD 114.63 Million |
Forecast Period: | 2025-2035 |
Forecast Period CAGR 2025-2035 : | 13.75% |
2035 Value Projection: | USD 473.10 Million |
Historical Data for: | 2020-2023 |
No. of Pages: | 208 |
Tables, Charts & Figures: | 110 |
Segments covered: | By Technology, By Application |
Companies covered:: | Sequential Bio, MicrobesNG, Oxford Nanopore Technologies, Genomics England, and Others |
Pitfalls & Challenges: | COVID-19 Impact, Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The market for United Kingdom metagenomics is primarily driven by as the result of the anticipated deployment of nationwide European WGS projects. Moreover, to support improved research, health policymaking, and individualized healthcare, this program seeks to provide safe access to genomes and related clinical data throughout European nations. The growing focus on the new bio molecule, the decline in sequencing costs, anticipated creation of biotechnology technologies aimed at optimizing laboratory procedures would encourage usage even further. Furthermore, it is expected that developments in bioinformatics and computational tools, which provide improved capabilities for verification and data analysis, will play a significant role in driving the growth of the market. Furthermore, deliberate efforts by businesses and academic organizations to advance cutting-edge technologies are anticipated to promote the growth of the metagenomics market.
Restraining Factors
However, the high expense of sequencing technologies and associated infrastructure continues to be a significant obstacle, restricting access to metagenomic techniques, particularly for smaller research institutes and developing nations. The expense of high-throughput sequencing systems, reagents, and data storage remains a deterrent to wider adoption, despite price reductions.
Market Segmentation
The United Kingdom metagenomics market share is classified into technology and application.
- The shotgun sequencing segment dominated the market in 2024 and is expected to grow at a significant CAGR during the forecast period.
The United Kingdom metagenomics market is divided by technology into shotgun sequencing, 16s sequencing, whole genome sequencing, and others. Among these, the shotgun sequencing segment dominated the market in 2024 and is expected to grow at a significant CAGR during the forecast period. This segment growth is driven due to dividing DNA into tiny pieces at random and then sequencing these pieces in parallel. This technique relies on no prior information about the organisms under study, making it highly useful for evaluating complicated microbial communities. Shotgun sequencing may detect and describe a huge number of microorganisms in a sample, including those that are unknown or difficult to cultivate. It also provides a comprehensive view of the entire microbial genome.
- The environmental segment held a significant share in 2024 and is expected to grow at a rapid pace during the forecast period.
The United Kingdom metagenomics market is segmented by application into environmental, clinical diagnostics, drug discovery, biotechnology, food & nutrition, and others. Among these, the environmental segment held a significant share in 2024 and is expected to grow at a rapid pace during the forecast period. This is because in agricultural and environmental protection, metagenomics research is rapidly growing. It uses gene screening or sequencing analysis to study microorganisms in a particular environment, which is a new way of looking at microbial ecosystems. Furthermore, ecological remediation, agricultural microbiome analysis, oceanic oil spills, and other biological studies are all studied using environmental metagenomics analysis.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom metagenomics market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Sequential Bio
- MicrobesNG
- Oxford Nanopore Technologies
- Genomics England
- Others
Recent Developments:
- In April 2025, the UK launched its first accredited metagenomics testing service, a groundbreaking step in diagnosing rare and hard-to-detect infections. Based at Great Ormond Street Hospital (GOSH), the service uses untargeted genomic sequencing to identify bacteria, viruses, and other pathogens directly from patient samples—even when traditional tests fail.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom metagenomics market based on the below-mentioned segments:
United Kingdom Metagenomics Market, By Technology
- Shotgun Sequencing
- 16S Sequencing
- Whole Genome Sequencing
- Others
United Kingdom Metagenomics Market, By Application
- Environmental
- Clinical Diagnostics
- Drug Discovery
- Biotechnology
- Food & nutrition
- Others
Need help to buy this report?